Results 31 to 40 of about 245,314 (316)

Current status of stroke in hemodialysis patients on a remote island.

PLoS ONE, 2023
ObjectivesHemodialysis patients have a higher incidence of stroke than healthy individuals. Hemodialysis patients living on remote islands are subject to additional distance and transportation difficulties.
Hikaru Nakamura, Takeshi Hiu, Yasuhito Yamamoto, Shinya Oda, Tsuyoshi Izumo, Takayuki Matsuo   +5 more
doaj   +1 more source

Antioxidant status in acute stroke patients and patients at stroke risk [PDF]

, 2004
Background and Purpose: Antioxidant enzymes like copper/ zinc superoxide dismutase (SOD), catalase and gluthatione peroxidase (GSHPx) are part of intracellular protection mechanisms to overcome oxidative stress and are known to be activated in vascular ...
Haberl, R. L., Winnefeld, K., S. Streck, Roskos, M., M. Roskos, R.L. Haberl, K. Winnefeld, Zimmermann, C., Streck, S., C. Zimmermann   +9 more
core   +1 more source

Thrombolysis in Acute Ischemic Stroke [PDF]

The Journal of the American Board of Family Medicine, 1998
The administration of rt-PA to patients with acute ischemic stroke can result in improved functional outcomes. The safe and effective use of rt-PA in routine medical practice requires that patients seek help early, have a well-defined onset of their symptoms, be carefully examined for contraindications to rt-PA, receive a CT scan and interpretation to ...
A, Luisi, A L, Hume
openaire   +2 more sources

D-dimer predicts early clinical progression in ischemic stroke: confirmation using routine clinical assays [PDF]

, 2006
<p><b>Background and Purpose:</b> Plasma D-dimer levels, measured using a research laboratory assay, independently predict progressing ischemic stroke.
Lowe, G.D.O., D. J. Stott, Rumley, A., Langhorne, P., M. Barber, A. Rumley, P. Langhorne, Barber, M., Stott, D.J., G. D.O. Lowe   +9 more
core   +1 more source

QT interval prolongation in patients with acute ischemic stroke: a report in northwest China

Journal of International Medical Research, 2019
Aims QT interval prolongation is common in patients with stroke and increases the risk of malignant arrhythmia and sudden death. Our aim was to analyze differences in the QT interval and electrocardiogram abnormalities between acute ischemic stroke ...
Jine Wu, Dilimulati Nizhamuding, Peng Liu, Yongrong Jiang, Hua Qiang, Chaofeng Sun, Chongliang Dai, Yanrong Yin   +7 more
doaj   +1 more source

Can the ischemic penumbra be identified on noncontrast CT of acute stroke? [PDF]

, 2007
<p><b>Background and Purpose:</b> Early ischemic changes on noncontrast CT in acute stroke include both hypoattenuation and brain swelling, which may have different pathophysiological significance.</p> <p><b>Methods:
Muir, K.W., McCormick, M., Baird, T., Coutts, S.B., Walker, L., Baird-Gunning, J.   +5 more
core   +1 more source

Acute Stroke Care in Mexico City: The Hospital Phase of a Stroke Surveillance Study

Brain Sciences, 2022
Background: Acute stroke care has greatly improved in recent decades. However, the increasing stroke mortality in low-to-middle income countries suggests that progress has not been reached completely by these populations.
Emmanuel Aguilar-Salas, Guadalupe Rodríguez-Aquino, Katya García-Domínguez, Catalina Garfias-Guzmán, Erika Hernández-Camarillo, Nayeli Oropeza-Bustos, Rubí Arguelles-Castro, Ameyalli Mitre-Salazar, Gloria García-Torres, Marco Reynoso-Marenco, Eduardo Morales-Andrade, Luis Gervacio-Blanco, Víctor García-López, Gabriel Valiente-Herves, Manuel Martínez-Marino, Fernando Flores-Silva, Erwin Chiquete, Carlos Cantú-Brito   +17 more
doaj   +1 more source

Factors associated with intracerebral hemorrhage after thrombolytic therapy for ischemic stroke pooled analysis of placebo data from the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II trials [PDF]

, 2009
<p><b>Background and Purpose:</b> A number of factors have been associated with postthrombolysis intracerebral hemorrhage, but these have varied across studies.</p> <p><b>Methods:</b> We examined patients with
Demchuk, A., Lees, K.R., Kasner, S.E., Messe, S.R., Cucchiara, B., Levine, S.R., Lyden, P., Sansing, L., Tanne, D.   +8 more
core   +1 more source

Additional outcomes and subgroup analyses of NXY-059 for acute ischemic stroke in the SAINT I trial [PDF]

, 2006
<p><b>Background and Purpose:</b> NXY-059 is a free radical-trapping neuroprotectant demonstrated to reduce disability from ischemic stroke. We conducted analyses on additional end points and sensitivity analyses to confirm our findings.
Lees, K.R., Diener, H.-C., Shuaib, A., Zivin, J.A., Davis, S.M., Wasiewski, W., Lyden, P., Emeribe, U., Ashwood, T., Hardemark, H.G., Davalos, A., Grotta, J.   +11 more
core   +1 more source

Dose escalation of desmoteplase for acute ischemic stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset [PDF]

, 2006
<p><b>Background and Purpose:</b> Desmoteplase is a novel plasminogen activator with favorable features in vitro compared with available agents.
Lees, K.R., Hacke, W.l, Sachara, C., Rowley, H.A., Furlan, A.J., Al, R.Y., Eyding, D., Albers, G.W., Soehngen, M., Warach, S.   +9 more
core   +1 more source